Articles On Virtus Health (ASX:VRT)
Title | Source | Codes | Date |
---|---|---|---|
The Overnight Report: V-Day Blues
World Overnight SPI Overnight (Dec) 6644.00 – 18.00 – 0.27% S&P ASX 200 6660.20 + 17.60 0.26% S&P500 3647.49 – 15.97 – 0.44% Nasdaq Comp 12440.04 + 62.17 0.50% DJIA 29861.55 – 184.82 – 0.62% S&P500 VIX 24.72 + 1.41... |
FNArena | VRT | 3 years ago |
The Overnight Report: Easing Back
World Overnight SPI Overnight (Dec) 6673.00 – 4.00 – 0.06% S&P ASX 200 6683.30 + 39.20 0.59% S&P500 3629.65 – 5.76 – 0.16% Nasdaq Comp 12094.40 + 57.62 0.48% DJIA 29872.47 – 173.77 – 0.58% S&P500 VIX 21.25 – 0.39 –... |
FNArena | VRT | 3 years ago |
Overnight: Easing Back
ShareCafeOvernight: Easing Back World Overnight SPI Overnight (Dec) 6673.00 – 4.00 – 0.06% S&P ASX 200 6683.30 + 39.20 0.59% S&P500 3629.65 – 5.76 – 0.16% Nasdaq Comp 12094.40 + 57.62 0.48% DJIA 29872.47 – 173.77 – 0.58%... |
ShareCafe | VRT | 3 years ago |
Overnight: Dow 30k
ShareCafeOvernight: Dow 30k World Overnight SPI Overnight (Dec) 6684.00 + 37.00 0.56% S&P ASX 200 6644.10 + 82.50 1.26% S&P500 3635.41 + 57.82 1.62% Nasdaq Comp 12036.79 + 156.15 1.31% DJIA 30046.24 + 454.97 1.54% S&am... |
ShareCafe | VRT | 3 years ago |
The Overnight Report: Dow 30k
World Overnight SPI Overnight (Dec) 6684.00 + 37.00 0.56% S&P ASX 200 6644.10 + 82.50 1.26% S&P500 3635.41 + 57.82 1.62% Nasdaq Comp 12036.79 + 156.15 1.31% DJIA 30046.24 + 454.97 1.54% S&P500 VIX 21.64 – 1.02 – 4.... |
FNArena | VRT | 3 years ago |
Overnight: Then There Were Three
ShareCafeOvernight: Then There Were Three World Overnight SPI Overnight (Dec) 6594.00 + 33.00 0.50% S&P ASX 200 6561.60 + 22.40 0.34% S&P500 3577.59 + 20.05 0.56% Nasdaq Comp 11880.63 + 25.66 0.22% DJIA 29591.27 + 327.79... |
ShareCafe | VRT | 4 years ago |
The Overnight Report: Then There Were Three
World Overnight SPI Overnight (Dec) 6594.00 + 33.00 0.50% S&P ASX 200 6561.60 + 22.40 0.34% S&P500 3577.59 + 20.05 0.56% Nasdaq Comp 11880.63 + 25.66 0.22% DJIA 29591.27 + 327.79 1.12% S&P500 VIX 22.64 – 1.06 – 4.4... |
FNArena | VRT | 4 years ago |
Reasons to be confident and cautious as ASX shares are bouncing back
Bring on November. Just one week into the new month and the S&P/ASX 200 Index (ASX: XJO) is up 6.3% since the closing bell sounded on 30 October. The index of the top 200 listed Aussie shares is now 2.5% above its 9 June highwater mark... |
Motley Fool | VRT | 4 years ago |
VRT – Morgans rates the stock as Add
ShareCafeVRT – Morgans rates the stock as Add Morgans note a strong start to the new year for Virtus Health that has resulted in lower debt and confirmation from the company that the deferred interim dividend from March 2020 will be paid in... |
ShareCafe | VRT | 4 years ago |
Scopo’s powerplays: Investors love a result, until they don’t
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Two out of... |
Stockhead | VRT | 4 years ago |
FNArena Corporate Results Monitor – 19-08-2020
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABP)) - Abacus Property Group ((AMC)) - Amcor ((AQR)) - Apn Convenience Retail Reit ((ARB)) - ARB Corp ((AHY)) - Asaleo Care ((BHP)) - BHP ((COH)) - Cochlear ((COL)) - C... |
FNArena | VRT | 4 years ago |
Why Tyro, Virtus Health, Webjet, & Westpac shares are dropping lower
The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is edging higher in late morning trade. At the time of writing the benchmark index is up 0.1% to 6,084.1 points. Four shares that have failed to follow the mark... |
Motley Fool | VRT | 4 years ago |
Virtus share price falls 5% as earnings plummet
The Virtus Health Ltd (ASX: VRT) share price has fallen 4.7% this morning after the IVF provider released its full year results. At the time of writing, the Virtus share price is trading at $3.03 after closing yesterday’s trade at $3.18. V... |
Motley Fool | VRT | 4 years ago |
Scopo’s powerplays: Investors love an ice queen
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week With repor... |
Stockhead | VRT | 4 years ago |
ASX reporting season calendar – August 2020
Hold onto your hats – it’s ASX reporting season! For investors, ASX reporting season rolls around twice per year. It’s that time of year when companies report their financial results, announce their dividend payments (or lack thereof) and,... |
Rask Media | VRT | 4 years ago |
The ASX stocks UBS has a ‘buy’ rating on in the wake of the COVID-19 disruption
The COVID-19 crisis has resulted in plenty of portfolio repositioning, as investors try and hitch a ride to some unexpected tailwinds that have arisen. In that environment, analyst Pieter Stoltz and the equity research team at UBS released... |
Stockhead | VRT | 4 years ago |
Scopo’s powerplays: Hemp hippies and wellness wonderlands
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week With quart... |
Stockhead | VRT | 4 years ago |
Scopo’s health powerplays: Markets are getting back to normal
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Victoria h... |
Stockhead | VRT | 4 years ago |
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
Since restrictions on elective surgery were lifted, some stocks in the elective surgery space have seen windfalls that may cancel out the COVID-19 losses. In late March, the Morrison government imposed restrictions on elective surgery to fr... |
Stockhead | VRT | 4 years ago |
Scopo’s health powerplays: Health goes up when markets go down
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Towards th... |
Stockhead | VRT | 4 years ago |
Scopo’s health powerplays: You’re all going to the pot, literally
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week As markets... |
Stockhead | VRT | 4 years ago |
Weekly Ratings, Targets, Forecast Changes – 15-05-20
By Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose... |
FNArena | VRT | 4 years ago |
The Overnight Report: Highly Uncertain
World Overnight SPI Overnight (Jun) 5366.00 – 58.00 – 1.07% S&P ASX 200 5421.90 + 18.90 0.35% S&P500 2820.00 – 50.12 – 1.75% Nasdaq Comp 8863.17 – 139.38 – 1.55% DJIA 23247.97 – 516.81 – 2.17% S&P500 VIX 35.28 + 2.... |
FNArena | VRT | 4 years ago |
The Overnight Report: Wave Theory
World Overnight SPI Overnight (Jun) 5320.00 – 68.00 – 1.26% S&P ASX 200 5403.00 – 58.20 – 1.07% S&P500 2870.12 – 60.20 – 2.05% Nasdaq Comp 9002.55 – 189.79 – 2.06% DJIA 23764.78 – 457.21 – 1.89% S&P500 VIX 33.04 +... |
FNArena | VRT | 4 years ago |
Overnight: Wave Theory
ShareCafeOvernight: Wave Theory World Overnight SPI Overnight (Jun) 5320.00 – 68.00 – 1.26% S&P ASX 200 5403.00 – 58.20 – 1.07% S&P500 2870.12 – 60.20 – 2.05% Nasdaq Comp 9002.55 – 189.79 – 2.06% DJIA 23764.78 – 457.21 –... |
ShareCafe | VRT | 4 years ago |
The Overnight Report: On The Shoulders Of Giants
World Overnight SPI Overnight (Jun) 5459.00 – 19.00 – 0.35% S&P ASX 200 5461.20 + 70.10 1.30% S&P500 2930.32 + 0.52 0.02% Nasdaq Comp 9192.34 + 71.02 0.78% DJIA 24221.99 – 109.33 – 0.45% S&P500 VIX 27.57 – 0.41 – 1... |
FNArena | VRT | 4 years ago |
Overnight: On The Shoulders Of Giants
ShareCafeOvernight: On The Shoulders Of Giants World Overnight SPI Overnight (Jun) 5459.00 – 19.00 – 0.35% S&P ASX 200 5461.20 + 70.10 1.30% S&P500 2930.32 + 0.52 0.02% Nasdaq Comp 9192.34 + 71.02 0.78% DJIA 24221.99 – 1... |
ShareCafe | VRT | 4 years ago |
ScoPo’s health powerplays: Getting our elective surgery (back) on
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. This week’s three big themes... |
Stockhead | VRT | 4 years ago |
Weekly Ratings, Targets, Forecast Changes – 27-03-20
By Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose... |
FNArena | VRT | 4 years ago |
ASX 200 lunch update: ANZ & Qantas rocket, Cochlear halted
At lunch on Wednesday the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is storming higher. The benchmark index is up 3.4% to 4,894.3 points at the time of writing. Here’s what is happening on the market today:... |
Motley Fool | VRT | 4 years ago |
Why Clover, InvoCare, REA Group, & Virtus Health shares are tumbling lower
In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain. At the time of writing the benchmark index is up 4% to 4,926.7 points. Four shares that have failed to follow the market higher today are... |
Motley Fool | VRT | 4 years ago |
Virtus Health shares tumble following coronavirus business update
The Virtus Health Ltd (ASX: VRT) share price is falling lower today, following a business update that was given in light of the escalating coronavirus crisis in Australia and internationally. At the time of writing, Virtus Health shares ar... |
Motley Fool | VRT | 4 years ago |
Virtus Health (ASX:VRT) appoints Ramsay’s Kate Munnings as CEO
Virtus Health (VRT) has appointed Kate Munnings as the new CEO Previously, Kate was the Chief Operating Officer at Ramsay Health Care Kate will be taking Sue Channon’s position, who will leave at the end of February, however, Kate will be... |
themarketherald.com.au | VRT | 4 years ago |
ALL ORDINARIES finishes higher Friday: 8 ASX shares you missed
Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.04% to... |
Motley Fool | VRT | 4 years ago |
Virtus Health (ASX:VRT) appoints Kate Munnings as new CEO
24 Jan 2020 - The Board of Virtus Health (ASX:VRT) is pleased to announce that they have appointed a new Group Chief Executive Officer. |
FNN | VRT | 4 years ago |
Virtus Health share price higher after naming Ramsay executive as its new CEO
The Virtus Health Ltd (ASX: VRT) share price is pushing higher on Friday. In morning trade the fertility treatment company’s shares are up 0.5% to $4.35. Why is the Virtus Health share price pushing higher? This morning Virtus Health annou... |
Motley Fool | VRT | 4 years ago |
9 of the most interesting biotech bosses in the game: part 2
You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,... |
Stockhead | VRT | 4 years ago |
Artificial Intelligence in Healthcare: Harrison.ai and HeraMED Under Discussion
Technology undoubtedly holds a significant importance in each sector of the industry, more so than ever, and certainly health care sector is no different. Use of technologies in the health care sphere has emerged as a boon for doctors, rese... |
Kalkine Media | VRT | 4 years ago |
Billionaires just backed a brand new healthtech startup using AI to predict IVF pregnancies in a $29 million debut raise
Brothers Dr Aengus Tran, and Dimitry Tran (pictured), who only launched Harrison.ai, their artificial intelligence healthcare startup, last year, have landed $29 million on debut in one of 2019’s most impressive capital raises. The round wa... |
Startup Daily | VRT | 4 years ago |
The Nexus for Health Care Stocks – VHT, MVP, TLX, NXS, VRT, HLS, AVH, MYX
On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT... |
Kalkine Media | VRT | 4 years ago |
Market Update: Understanding Performance of Australian Markets on November 20, 2019?
Stock markets in Australia are affected by economic uncertainties as well as by health of global economy. If the global growth comes into question, investors might decide to deploy investable capital towards safer asset classes, and they mi... |
Kalkine Media | VRT | 5 years ago |
Tale of 2 IVF Stocks – Monash IVF Group, Virtus Health
In vitro fertilization (IVF) is the process to treat infertility and other genetic issues with artificial fertilization. Now a days the process of artificial fertilization has become a preferred and most efficient assisted reproductive tech... |
Kalkine Media | VRT | 5 years ago |
Why Bega Cheese, Domino’s, Midway, & Virtus Health shares are tumbling lower
The S&P/ASX 200 index has given back the majority of its morning gains but is just about keeping its head above water. At the time of writing the benchmark index is up a few points to 6,743.5 points. Four shares that have failed to fol... |
Motley Fool | VRT | 5 years ago |
Why the Bega Cheese share price is crashing lower today
In morning trade the Bega Cheese Ltd (ASX: BGA) share price has come under pressure following an update ahead of its annual general meeting. At the time of writing the diversified food company’s shares are down 17% to a 52-week low of $3.7... |
Motley Fool | VRT | 5 years ago |
Virtus Health (ASX:VRT) CEO succession
29 Oct 2019 - Virtus Health Limited (ASX:VRT) CEO Sue Channon will step down from her position after 7 years with the fertility company. |
FNN | VRT | 5 years ago |
Scentre Group and URW Under Review
Cognitive biases can have their benefits. Last week, we downgraded former and long-standing Buy recommendation Virtus Health to Sell. The company has been within the purview of three analysts over the years but recently the investment case... |
Intelligent Investor | VRT | 5 years ago |
A look at companies exposed to tailwinds
With reporting season sprinting to the end, on a fundamental level it is not all doom and gloom, there are winners (and losers). We notice a clear winner in companies with direct consumer exposure. What are our observations on the cyclical... |
Montgomery | VRT | 5 years ago |
Weekly Ratings, Targets, Forecast Changes – 26 August 2019
By Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For th... |
FNArena | VRT | 5 years ago |
Virtus Health downgraded to Sell
With a new competitor starting up and a deteriorating investment case, it's time to let go. |
Intelligent Investor | VRT | 5 years ago |
Why the Monash IVF share price crashed 25% lower today
The worst performer on the All Ordinaries index by some distance on Thursday has been the Monash IVF Group Ltd (ASX: MVF) share price. The fertility treatment company’s shares have crashed 25% lower to $1.06 in late morning trade. Why has... |
Motley Fool | VRT | 5 years ago |